🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Papers
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant

Cell Host & Microbe(2024)10.1016/j.chom.2023.12.010Source: DataRank Database

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant is a research paper published in Cell Host & Microbe (2024). On theSindex it has a DataRank of 1.3. It has been cited 38 times, with 33 citing works in its 1-hop citation network.

N/A

1.3DataRank · unranked

Scored on demand from live citation data

Open Access38 citations · 33 citing works in its network

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 11.19)OA: hybridTopics (48)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

FFindable (1/2)

Has DOI

AAccessible (1/2)

Open Access

IInteroperable (0/2)

RReusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 43%Citation Network 57%

Base Score Contribution

0.550

From this paper's citation signal

Citation Network Contribution

0.739

From 24 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 33 citers.

Arming up against Omicron subvariants
Cell Host & Microbe20249 citations10 referencesContributes 0.230
Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1
Viruses202418 citations54 referencesContributes 0.055
T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots
Nature Immunology202527 citations64 referencesContributes 0.052
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants
Vaccines20245 citations38 referencesContributes 0.047
Deconvoluting TCR-dependent and -independent activation is vital for reliable Ag-specific CD4 + T cell characterization by AIM assay
Science Advances202517 citations67 referencesContributes 0.043

Authors (24)

Yu Gao ORCID,Jinghua Wu ORCID,Oriana Ribeiro,Puran Chen ORCID,Peter Bergman ORCID

Live enrichment

PubMed:38211584 OpenAlex:https://openalex.org/W4390694407

U.S. Department of Health and Human Services

Grant: 2018-02330

U.S. Department of Health and Human Services

Grant: 2020-06121

U.S. Department of Health and Human Services

Grant: 2021-01141

U.S. Department of Health and Human Services

Grant: 2021-04779

U.S. Department of Health and Human Services

Grant: 2021.0136

U.S. Department of Health and Human Services

Grant: 2022-01313

Center for Innovative Medicine

Grant: FoUI-988204

Åke Wiberg Stiftelse

Grant: M20-0190

Karolinska Institutet

Grant: 2019-00969

Karolinska Institutet

Grant: 2021-00513

Karolinska Institutet

Grant: 2022-01719

Deutsche Forschungsgemeinschaft

Grant: 496946670

Cancerfonden

Grant: 22 2237 Pj

Svenska Sällskapet för Medicinsk Forskning

Grant: CG-22 0009

European Research Council

Grant: 101046016

European Cohorts of Patients and Schools to Advance Response to Epidemics

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

Knut och Alice Wallenbergs Stiftelse

European Research Council

National Institute of Allergy and Infectious Diseases

Vetenskapsrådet

Cancerföreningen i Stockholm

National Institutes of Health

FWCI

11.19

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S193131282300505X-fx1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S193131282300505X-fx1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S193131282300505X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S193131282300505X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chom.2023.12.010

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0303 health sciences03 medical and health sciencesHumansMemory T CellsCD8-Positive T-LymphocytesCOVID-19SARS-CoV-2EpitopesSpike Glycoprotein, CoronavirusAntibodies, ViralSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2Memory T CellsAntibodies, ViralEpitopesHumansCD8-Positive T-LymphocytesSpike Glycoprotein, Coronavirus

Keywords

BiologyImmune systemEpitopeCD8ImmunologyCoronavirusT cellVirologySpike (software development)AntibodyCoronavirus disease 2019 (COVID-19)MedicineCellular immunityT cellsSars-cov-2Ba.1Ba.2.86Infectious MedicineCOVID-19InfektionsmedicinCD8-Positive T-LymphocytesAntibodies, ViralMemory T CellsEpitopesSpike Glycoprotein, CoronavirusHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (10)

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

N/A

1.2DataRank · unranked

Science(2021)

co-cited

10.1126/science.abf4063

A molecular single-cell lung atlas of lethal COVID-19

Top 4%

5.3DataRank

Nature(2021)

co-cited

10.1038/s41586-021-03569-1

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

N/A

0.978DataRank · unranked

Cell Reports Medicine(2021)

co-cited

10.1016/j.xcrm.2021.100355

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

N/A

0.954DataRank · unranked

Cell Reports Medicine(2021)

co-cited

10.1016/j.xcrm.2021.100204

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

N/A

0.946DataRank · unranked

Nature Medicine(2021)

co-cited

10.1038/s41591-021-01507-2

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

N/A

13.9DataRank · unranked

Nature Medicine(2021)

co-cited

10.1038/s41591-021-01386-7

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

N/A

0.920DataRank · unranked

Cell Reports Medicine(2021)

co-cited

10.1016/j.xcrm.2021.100354

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

N/A

0.881DataRank · unranked

Science(2021)

co-cited

10.1126/science.abj9853

SARS-CoV-2 infection generates tissue-localized immunological memory in humans

Science Immunology(2021)

co-cited

10.1126/sciimmunol.abl9105

Immune signatures underlying post-acute COVID-19 lung sequelae

Science Immunology(2021)

co-cited

10.1126/sciimmunol.abk1741